Zosano Pharma Corp. (ZSAN) Stock in Decline, Here’s the Cause
Zosano Pharma Corp. (ZSAN), a clinical-stage biopharmaceutical company, has declined 3.36% in the premarket trading session. Consequently, the stock was trading at $0.19 when last checked. During Thursday’s regular trading session, the stock rose by 6.79% to close the day at $0.20. The decline in aftermarket followed the announcement of financial results. Q4 & FY 2021 […]
